Showing results (1-10 of 137) with videos related to
Sort By:
Pageof 14
Expert Opinion on Pharmacotherapy|July 8, 2024
Advances in pharmacotherapy for sickle cell disease: what is the current state of play?Sheinei Alan, Julie KanterHematology. American Society of Hematology. Education Program|December 10, 2021
Gene therapy for sickle cell disease: where we are now?Julie Kanter, Corey FalconClinical Pharmacology and Therapeutics|October 17, 2019
Innovations in Targeted Anti-Adhesion Treatment for Sickle Cell DiseaseJulie Kanter, Sophie LanzkronExperimental Biology and Medicine (Maywood, N.J.)|December 24, 2025
Clinical data comparison for FDA-approved gene therapies in sickle cell diseaseAlexis Leonard, Julie KanterBritish Journal of Haematology|November 25, 2024
Avascular necrosis in sickle cell disease needs more definitive treatment optionsNajibah A Galadanci, Julie KanterClinical Pediatrics|August 9, 2014
When is the optimal time to screen for Chlamydia in adolescents and young adults with sickle cell disease?Gabriella Bluett-Mills, Julie KanterBlood Reviews|October 8, 2013
Management of sickle cell disease from childhood through adulthoodJulie Kanter, Rebecca Kruse-JarresTherapeutic Advances in Hematology|October 16, 2020
Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell diseaseIfeyinwa Osunkwo, Deepa Manwani, Julie KanterJournal of Pediatric Endocrinology & Metabolism : JPEM|August 11, 2012
Septo-optic dysplasia and hemophagocytic lymphohistiocytosis in an infantEmily Kate Brumfield, Julie Kanter WashkoJournal of Clinical Medicine|December 11, 2019
International Differences in Outpatient Pain Management: A Survey of Sickle Cell DiseaseNadirah El-Amin, Paul Nietert, Julie KanterPageof 14